Immunotoxic effects of carbon tetrachloride--the effect on morphology and function of the immune system in mice. 1996

D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
National Institute of Public Health, Prague, Czech Republic.

Carbon tetrachloride (CCL4), a polychlorinated hydrocarbon, is known for its hepatotoxicity, neurotoxicity and skin irritancy. Some epidemiological studies suggest possible carcinogenicity of CCl4. This substance is still present in industrial wastes and in the environment. As the major role of the immune system is immunosurveillance against cancer, we decided to follow the morphological and functional changes of the immune system during acute and subchronic exposures to CCL4 in mice. Mice (A/PhJ) were exposed i.p. to 1.7 mmol CCl4/kg b.w./day administered in olive oil (total volume 0.2 ml), for 2, 7, 14, 23 days. We evaluated: morphology of thymus, spleen and peripheral lymph nodes, immunopathology (thymus and spleen weight, spleen cellularity, number of peripheral blood leukocytes), non-specific immunity (phagocytosis, NK activity), humoral immunity (number of PFC after SRBC immunization, LPS mitogen response), cell-mediated immunity (PHA, ConA mitogen response). Morphological examination showed significant activation of lymphoid tissues in T-cell dependent areas. B-cell areas were also activated, but the formation of active germinal centers in lymphatic follicles has not been observed. The natural immunity was affected in a time dependent manner. A slightly hepatotoxic dose of CCl4 had a significant stimulative effect on phagocytosis and natural killer activity when administered in short-term schedule ("acute exposure"). Subchronic administration of the same dose led to suppression of phagocytosis and Nk activity. Similarly, the lymphocyte response to non-specific mitogens was enhanced during short-term exposure and significantly impaired when CCl4 was administered in long-term schedule. Antigen specific immune response to SRBC was impaired immediately after short-term exposure to CCl4 which suggests that the substance might affect the immunoglobuline proteosynthesis at the cellular level.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D002251 Carbon Tetrachloride A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed) Tetrachloromethane,Tetrachloride, Carbon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000922 Immunotoxins Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect. Affinotoxin,Antibody-Toxin Conjugate,Antibody-Toxin Conjugates,Antibody-Toxin Hybrid,Antibody-Toxin Hybrids,Chimeric Toxins,Cytotoxin-Antibody Conjugate,Cytotoxin-Antibody Conjugates,Monoclonal Antibody-Toxin Conjugate,Targeted Toxin,Targeted Toxins,Toxin Carriers,Toxin Conjugates,Toxin-Antibody Conjugate,Toxin-Antibody Conjugates,Toxin-Antibody Hybrid,Toxin-Antibody Hybrids,Toxins, Chimeric,Toxins, Targeted,Affinotoxins,Chimeric Toxin,Immunotoxin,Monoclonal Antibody-Toxin Conjugates,Toxin Carrier,Toxin Conjugate,Antibody Toxin Conjugate,Antibody Toxin Conjugates,Antibody Toxin Hybrid,Antibody Toxin Hybrids,Antibody-Toxin Conjugate, Monoclonal,Antibody-Toxin Conjugates, Monoclonal,Carrier, Toxin,Carriers, Toxin,Conjugate, Antibody-Toxin,Conjugate, Cytotoxin-Antibody,Conjugate, Monoclonal Antibody-Toxin,Conjugate, Toxin,Conjugate, Toxin-Antibody,Conjugates, Antibody-Toxin,Conjugates, Cytotoxin-Antibody,Conjugates, Monoclonal Antibody-Toxin,Conjugates, Toxin,Conjugates, Toxin-Antibody,Cytotoxin Antibody Conjugate,Cytotoxin Antibody Conjugates,Hybrid, Antibody-Toxin,Hybrid, Toxin-Antibody,Hybrids, Antibody-Toxin,Hybrids, Toxin-Antibody,Monoclonal Antibody Toxin Conjugate,Monoclonal Antibody Toxin Conjugates,Toxin Antibody Conjugate,Toxin Antibody Conjugates,Toxin Antibody Hybrid,Toxin Antibody Hybrids,Toxin, Chimeric,Toxin, Targeted

Related Publications

D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
February 1973, Biochimica et biophysica acta,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
November 1953, A.M.A. archives of neurology and psychiatry,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
July 2019, Journal of cellular biochemistry,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
August 1982, Toxicology and applied pharmacology,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
June 1952, Acta pathologica et microbiologica Scandinavica. Supplementum,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
October 1973, Biochimica et biophysica acta,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
October 1959, Nature,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
April 1973, Ethiopian medical journal,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
January 1953, Transactions of the American Neurological Association,
D Jírová, and I Sperlingová, and M Halasková, and H Bendová, and L Dabrowská
June 1970, Japanese journal of pharmacology,
Copied contents to your clipboard!